These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3241328)

  • 1. [Clinical evaluation of S 6472 granule preparation (sustained-release cefaclor) in chronic bronchitis].
    Hiraga Y; Omichi M; Sasaoka S
    Jpn J Antibiot; 1988 Sep; 41(9):1304-8. PubMed ID: 3241328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of S 6472 granule preparation (sustained-release cefaclor) in chronic bronchitis].
    Tanimoto H; Nakamori Y
    Jpn J Antibiot; 1988 Sep; 41(9):1319-24. PubMed ID: 3241331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical studies on S 6472 granule preparation (sustained-release cefaclor) in chronic respiratory tract infections].
    Aonuma S; Oizumi K; Watanabe A; Tokue Y; Honda Y; Ono R; Kitamura N; Konno K; Satoh K
    Jpn J Antibiot; 1988 Sep; 41(9):1309-12. PubMed ID: 3241329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical examination of S 6472 (sustained release preparations of cefaclor on chronic respiratory tract infection].
    Hayashi I; Ohnuma K
    Jpn J Antibiot; 1988 Sep; 41(9):1313-8. PubMed ID: 3241330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study of S 6472 granule preparation (sustained-release cefaclor) in chronic respiratory airway infections].
    Odagiri S; Matsunaga K; Suzuki K; Murohashi K; Numata H; Takahashi K; Yamaki I; Ishii S
    Jpn J Antibiot; 1988 Sep; 41(9):1325-33. PubMed ID: 3241332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral cefaclor for treatment of bronchitis--a comparative double-blind study versus amoxycillin.
    Beumer HM; Veldkamp J
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):113-7. PubMed ID: 7068283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute bacterial bronchitis and pneumonia with cefaclor.
    Mogabgab WJ; Pollock B; Beville RB; Gentry LO; Jemsek JG
    Postgrad Med J; 1979; 55 Suppl 4():62-6. PubMed ID: 44908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fundamental and clinical studies of S 6472 (sustained release preparation of cefaclor) in the pediatric field].
    Sugita M; Toyonaga Y; Nakamura H; Kurosu Y; Hori M
    Jpn J Antibiot; 1985 Sep; 38(9):2444-52. PubMed ID: 3908736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fundamental and clinical studies of a sustained release preparation of cefaclor in the surgical field].
    Yura J; Shinagawa N; Ishikawa S; Tachi Y; Kobe A; Shibata Y; Ito T; Tanabe M; Fukuhara A; Sakakibara O
    Jpn J Antibiot; 1985 Mar; 38(3):859-68. PubMed ID: 3897613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
    Alanis A; Longest KA; Senetar JE; Dere WH
    Postgrad Med J; 1992; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acute bronchitis and pneumonia with cefaclor.
    Mattson K; Renkonen OV; Laitinen L; Nikander-Hurme R
    Postgrad Med J; 1979; 55 Suppl 4():59-61. PubMed ID: 398482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical examination of ceftibuten in acute bronchitis].
    Hayashi I; Onuma K; Hasuike M; Ishii T
    Jpn J Antibiot; 1990 May; 43(5):761-7. PubMed ID: 2391747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of S6472 (prolonged action preparation of cefaclor) in the treatment of skin and soft tissue infections. A double blind comparison of S6472 and cefaclor].
    Sakai K; Fujimoto M; Ueda T; Yura J; Shinagawa N; Ishikawa S; Tachi Y; Kobe A; Shibata Y; Doi S
    Jpn J Antibiot; 1985 Oct; 38(10):2716-34. PubMed ID: 3908726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A double-blind comparative study on the efficacy of S6472, cefaclor, in the treatment of bacterial bronchitis].
    Oshima S; Yokoyama Y; Kikuiri T; Murakami T; Nishihara H; Shimizu T; Abe M; Kurihara Y; Itoh C; Takeuchi K
    Jpn J Antibiot; 1986 Oct; 39(10):2726-53. PubMed ID: 3543432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical studies of S6472 in otorhinolaryngologic infections].
    Baba S; Kinoshita H; Mori Y; Suzuki K; Ohyama M; Katsuta K; Furuta S; Ohno I; Noboru T; Yamamoto M
    Jpn J Antibiot; 1985 Jul; 38(7):1750-60. PubMed ID: 4068219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefaclor in the treatment of infective exacerbations of chronic bronchitis in cigarette smokers.
    Cazzola M; Franco C; Gioia V; Legnani D; Mancini V; Polverino M; Sevieri G
    J Chemother; 1991 Aug; 3(4):245-9. PubMed ID: 1779259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Report of experiences with the oral cephalosporin-derivative cephaclor in respiratory tract infections].
    Spath P
    Wien Med Wochenschr; 1983 Jan; 133(1):27-30. PubMed ID: 6837048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbation of chronic bronchitis.
    Cazzola M; Di Perna F; Boveri B; Di Marco F; Diamare F; Centanni S
    J Chemother; 2000 Jun; 12(3):216-22. PubMed ID: 10877516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of sustained release preparations of cefaclor in dental infections. Comparative double blind clinical studies of sustained release preparations with a regular preparation of cefaclor].
    Horii M; Shimada S; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Inaba O; Takada S; Kimura J
    Jpn J Antibiot; 1985 Apr; 38(4):1117-40. PubMed ID: 3897614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of cefaclor and tetracycline in the treatment of bacterial bronchitis.
    Hurst DJ
    Clin Ther; 1984; 6(2):163-9. PubMed ID: 6231104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.